AMY DONAHEY: Open Payments
NPI 1144832346 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,485 in 79 payments from 16 companies in 2025. Trend: 2023 $1,354 · 2024 $1,668 · 2025 $1,485
Food & beverage: $1,485
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $237 |
| PFIZER INC. | 12 | $222 |
| Novo Nordisk Inc | 13 | $216 |
| ABBVIE INC. | 12 | $199 |
| Lilly USA, LLC | 5 | $100 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $100 |
| Amgen Inc. | 4 | $75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $54 |
| Exact Sciences Corporation | 3 | $52 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $46 |
Products named: AIRSUPRA, VRAYLAR, NURTEC ODT, Kerendia, Wegovy, MOUNJARO, FARXIGA, Ozempic.
Industry payments across FL — which companies pay providers there.
